Navigation Links
Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
Date:5/26/2011

ffels.  "The future drivers for success in pharmaceuticals will depend on matching the medical need with the best science and operational excellence.  We have strong therapeutic area expertise to anticipate the medical need and the scientific acumen to access the best science internal or external.

"Our development programs incorporate an outcomes-based approach, embedding customer, physician, and patient insights, while our broad-based expertise and global development operations allow us to deliver competitive products globally, with enhanced productivity and accelerated timelines," Stoffels added.

Joaquin Duato, Worldwide Chairman, Pharmaceuticals, will review the company's growing core pharmaceuticals businesses and key category strength.  Among some of the core growth businesses being discussed today are market-leading immunology medicines, REMICADE®, SIMPONI®, STELARA®, and the long-acting injectable anti-psychotics, RISPERDAL® CONSTA® and INVEGA® SUSTENNA®.  Mr. Duato, Dr. Stoffels and R&D leaders will discuss the company's expectations for new filings and early-stage compounds across the pharmaceuticals business'  five therapeutic areas throughout the day.

"Launch leadership in the United States for 2010 demonstrates not only the strength of our pipeline but our capacity to successfully commercialize important medicines," says Mr. Duato.  "We are leveraging that expertise in key markets around the world, particularly as we launch important global compounds in 2011. I have great confidence in our ability to deliver the promise of our portfolio to make a real difference in patients' lives."  

Full copies of the presentations, as well as a replay and podcast, will be available approximately two hours after the live webcast concludes.  

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the p
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Multiple Sclerosis Drugs Market 2014-2018" ... is a chronic, inflammatory medical condition that results in ... damaged because of an abnormal response by the immune ... (CNS). It is a potentially debilitating disease in which ...
(Date:8/29/2014)... 29, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... Chief Executive Officer, will present at the CL King ... Tuesday, September 9, 2014 at 12:30 p.m. ET. The ... Hotel in New York City . ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PR ... ("DelMar" "the Company") today announced the filing of June ... changed its fiscal year end to June 30th in ... stock on a national securities exchange in the timeliest ... with the United States Securities Exchange Commission can be ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... NEW YORK, Sept. 6, 2011 ... research report is available in its ... Contract Research Organizations (CRO) - Asia-Pacific, ... Benefit from Rising Financial and Regulatory ...
... BLUE BELL, Pa., Sept. 6, 2011 Inovio Pharmaceuticals, ... in the development of therapeutic and preventive vaccines against ... board with the appointment of two prominent leaders in ... advisory board are Dr. Thomas S. Edgington, Emeritus Professor ...
Cached Medicine Technology:Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 2Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 3Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 4Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 5Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 6Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 7Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 8Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 9Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets 10Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board 2Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board 3Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board 4Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board 5
(Date:8/30/2014)... Colorado (PRWEB) August 30, 2014 Daily Gossip ... called the Make Him Desire You program, who shows a ... , The author of this method says that the program ... , The Make Him Desire You review indicates that the ... amazing insider advice and his great techniques to make a ...
(Date:8/30/2014)... 2014 Daily Gossip reveals in its recently ... a method created by Sarah Summer, who can perfectly understand ... of this new program actually had to deal with this ... be able to access it, in an all-natural holistic cure ... finding an effective cure for yeast infection. The author of ...
(Date:8/30/2014)... New York (PRWEB) August 30, 2014 ... combination of Nutrition and Pharameuticals. Nutraceuticals is a ... extracting healthy ingredients from natural food sources. Nutraceutical ... health benefits to the human body. Nutraceutical health ... diet supplements, fortified foods and more. Although nature ...
(Date:8/30/2014)... August 30, 2014 Ticket Down ... Open Tennis Championship tickets in NYC. This ... code US-OPEN-2014 for all day session, evening session, courtside ... sales for this prestigious Grand Slam Tournament. , The ... 8/30/14 , US Open Tennis Championship: Men's/Women's 3rd Round ...
(Date:8/30/2014)... After offering hyperbaric oxygen therapy ... past several years, Dr. Roy Schmidt and the ... a scholarship program for veterans who have been ... held this summer to discuss veterans’ needs ( ... shed light on the large number of veterans ...
Breaking Medicine News(10 mins):Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:Natural Cure for Yeast Infection Review Exposes New Natural Treatment 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 2Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 3Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 4Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 5Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2
... Ophthalmology hosts event October 24 benefiting,Juvenile Diabetes Research ... Oct. 17 Oklahoma Academy of,Ophthalmology (OAO) hosts ... Research Foundation (JDRF) Central Oklahoma Chapter., Actor, ... the,event. Lorena and Gary Story of Oklahoma City ...
... (Caltech) have created a "plug-and-play" synthetic RNA device--a sort ... in and responding to more than one biological or ... such devices could have a multitude of potential medical ... tumor cells or determine when to turn modified genes ...
... Behind New Resource, KUMASI, Ghana, Oct. 17 ... new hopeXchange Medical Center, a high quality,diagnostic and ... the ceremony, President Kufuor welcomed a high-profile mission,delegation ... the Cure(R),s President,and CEO Hala Moddelmog, and acknowledged ...
... MINNETONKA, Minn., Oct. 17 Cancer and its ... amounts of calories,protein and nutrients they need to help ... lose significant amounts of lean,muscle mass and weight because ... strong aversion to foods. These symptoms can lead to ...
... Mich., Oct. 17 Chrysler LLC and Henry,Ford ... bring an,innovative diabetes program to its Sterling Stamping ... the Henry Ford Health System,and is intended to ... existing workplace wellness initiatives. All employees at the,site ...
... Satyam Computer,Services Ltd. (NYSE: SAY ), a ... reported US GAAP results for its second,quarter, which ... Despite a challenging market that impacted several key ... exceeded its guidance in,the second quarter. Revenue was ...
Cached Medicine News:Health News:Second Annual 'Eye Ball' Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology 2Health News:Second Annual 'Eye Ball' Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology 3Health News:Caltech engineers build first-ever multi-input 'plug-and-play' synthetic RNA device 2Health News:New Specialty Hospital Dedicated in Ghana is Key Component of Susan G. Komen for the Cure(R)'s Debut in Africa 2Health News:New Specialty Hospital Dedicated in Ghana is Key Component of Susan G. Komen for the Cure(R)'s Debut in Africa 3Health News:New Specialty Hospital Dedicated in Ghana is Key Component of Susan G. Komen for the Cure(R)'s Debut in Africa 4Health News:Strong Bodies Battle Better 2Health News:Strong Bodies Battle Better 3Health News:Chrysler LLC Launches Workplace Diabetes Education Program 2Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 2Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 3Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 4Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 5Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 6Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 7Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 8Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 9Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 10
... to having been designed exclusively for vascular treatments, ... the Smartepil range which ensures fast amortisation of ... systems, it can be fitted with a polarised ... the target to be treated as well as ...
... SmartLite Derm is a KTP laser, ... of 532 nm (frequency doubled Nd:YAG) for ... by the comfortable color LCD Touch-screen. ... available are 0.3, 0.5, 0.7 and 1.0 ...
... a new and powerful instrument for ... system (MEL @308 nm - UVB) ... vitiligo. Designed to treat recalcitrant plaques, ... exposure of extensive lesions without irradiating ...
... a CO2 laser system with CW intensities ... dealing with all therapeutic application in modern ... medium-to-high intensities in super-pulsed mode, designed for ... It is also capable of supplying soft ...
Medicine Products: